Brief: Medicure Announces FDA Approval Received For Prexxartan
Dec 19 (Reuters) - Medicure Inc MPH.V :
* MEDICURE ANNOUNCES FDA APPROVAL RECEIVED FOR PREXXARTAN
* MEDICURE INC SAYS CARMEL BIOSCIENCES RECEIVED FINAL
APPROVAL OF
ITS NDA FROM U.S. FDA FOR PREXXARTAN (VALSARTAN) ORAL SOLUTION
Source text for Eikon: ID:nCNWVH9V2a
Further company coverage: MPH.V
(((Bangalore.newsroom@thomsonreuters.com;);))
Recent news on Medicure
See all newsBrief: Medicure Announces Resignation Of Board Member And Grant Of Stock Options
Brief: Medicure Posts Qtrly Earnings Per Share $0.11
Brief: Medicure Reports Financial Results For Quarter Ended June 30, 2022
Brief: Medicure Announces Resignation Of CFO And Succession Plan
Brief: Algernon Pharmaceuticals Appoints James Kinley As CFO Effective From December 1, 2021